PBAC Public Summary Documents - July 2017
Page last updated: 9 November 2018
Public Summary Documents relating to the July 2017 PBAC meeting.
- Abiraterone: Tablet 500 mg; Zytiga®
- Adalimumab: Injection 40 mg in 0.8 mL vial; Humira® - Updated 26 October 2018
- Alectinib: Capsule 150 mg; Alecensa®
- Amino acid formula supplemented with prebiotics, probiotics and long chain polyunsaturated fatty acids: Oral powder, 400g; Neocate Syneo®
- Amino acid formula with carbohydrate, vitamins, minerals and trace elements without phenylalanine,supplemented with docosahexaenoic acid: Sachets containing oral powder 33 g, 30; PKU Synergy®
- Amino acid formula with vitamins and minerals, without phenylalanine: Oral liquid 125 mL, 30; PKU Lophlex LQ 20®: Sachets containing oral powder 27.8 g, 30; PKU Lophlex®
- Anakinra: Injection 100 mg in 0.67 mL single use pre-filled syringe; Kineret®
- Asfotase alfa: Injection 18 mg in 0.45 mL, vial, Injection 28 mg in 0.7 mL, vial, Injection 40 mg in 1 mL, vial, Injection 80 mg in 0.8 mL, vial; Strensiq®
- Auranofin: Tablet 3 mg; Ridaura®
- Baclofen: Intrathecal injection 40 mg in 20mL; Sintetica Baclofen Intrathecal®
- Balsalazide: Capsule containing balsalazide sodium 750 mg; Colazide®
- Baricitinib: Tablet 2 mg, Tablet 4 mg, Olumiant®
- Budesonide: Tablet 9 mg; Cortiment®
- Budesonide with eformoterol: Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose, 120 doses; Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with eformoterol fumarate dihydrate 12 micrograms per dose, 120 doses; DuoResp®, Spiromax
- Carfilzomib: Powder for I.V. infusion 30 mg and 60 mg; Kyprolis®
- Dapagliflozin: Tablet 10 mg (as propanediol monohydrate); Forxiga®
- Dapagliflozin with metformin: Tablet (modified release) containing 5 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride, Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 500 mg metformin hydrochloride, Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride; Xigduo® XR
- Docetaxel: Solution concentrate for I.V. infusion 160 mg in 8 Ml; Docetaxel Accord®
- Eculizumab: Solution concentrate for I.V.infusion 300 mg in 30 mL; Soliris®
- Enzalutamide: Capsule 40 mg; Xtandi®
- Epoetin lambda: Injection 1,000 units in 0.5 mL pre-filled syringe, Injection 2,000 units in 1 mL pre-filled syringe, Injection 3,000 units in 0.3 mL pre-filled syringe, Injection 4,000 units in 0.4 mL pre-filled syringe, Injection 5,000 units in 0.5 mL pre-filled syringe, Injection 6,000 units in 0.6 mL pre-filled syringe, Injection 8,000 units in 0.8 mL pre-filled syringe, Injection 10,000 units in 1 mL pre-filled syringe; Novicrit®
- Evolocumab: Injection 420 mg in 3.5 mL, single dose autoinjector; Repatha®
- Febuxostat: Tablet 80 mg; Adenuric®
- Fentanyl: Tablet (sublingual) 100 micrograms (as citrate) Tablet (sublingual) 200 micrograms (as citrate); Abstral®
- Glatiramer: Injection containing glatiramer acetate 20 mg in 1 mL single dose pre-filled syringe, Injection containing glatiramer acetate 40 mg in 1 mL single dose pre-filled syringe; Copaxone®
- Glecaprevir with pibrentasvir: Tablet containing 100 mg glecaprevir with 40 mg pibrentasvir, Maviret®
- Glycomacropeptide formula with long chain polyunsaturated fatty acids and docosahexaenoic acid and low in phenylalanine: Sachets containing oral powder 27 g, 30; Sachets containing oral powder 35 g, 30; PKU Sphere® 15, PKU Sphere® 20
- Goserelin: 3.6 mg implant; Zoladex Implant®
- Guanfacine: Tablet containing guanfacine hydrochloride 1 mg, Tablet containing guanfacine hydrochloride 2 mg, Tablet containing guanfacine hydrochloride 3 mg,Tablet containing guanfacine hydrochloride 4 mg; Intuniv®
- Human papillomavirus 9-valent vaccine: Injection 0.5 mL, pre-filled Syringe Gardasil® 9
- Icatibant: Injection 30 mg (as acetate)in 3 mL single use pre-filled syringe; Firazyr®
- Lanreotide: Injection 120 mg (as acetate) in single dose pre-filled syringe; Somatuline® and Autogel®
- Liraglutide: Injection 6 mg/mL, 3 mL pre-filled pen; Victoza®
- Lumacaftor with ivacaftor: Tablet containing lumacaftor 200 mg with ivacaftor 125 mg; Orkambi®
- Mannitol: Pack containing 280 capsules containing powder for inhalation 40 mg and 2 inhalers; Bronchitol®
- Methoxsalen: Solution for blood fraction, 20 microgram per mL, 10 mL; Uvadex® - Updated 9 November 2018
- Migalastat: Capsule containing migalastat hydrochloride 150 mg; Galafold®
- Nicotine: Gum 2 mg, Gum 4 mg, Lozenge 2 mg, Lozenge 4 mg; Nicotinell Chewing gum® and Nicotinell lozenge®
- Ocrelizumab: Solution concentrate for I.V. infusion 300 mg in 10 mL; Ocrevus®
- Pegfilgrastim: Injection 6 mg in 0.6 mL single use pre-filled syringe; Neulasta®, Ristempa®
- Pembrolizumab: Powder for injection 50 mg, Solution for I.V. infusion 100 mg in 4 mL; Keytruda®
- Perampanel: Tablets (as hemisesquihydrate); 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, 12 mg; Fycompa®
- Pralatrexate: Solution for I.V. infusion 20 mg in 1mL; Folotyn®
- Propranolol: Oral liquid 3.75 mg per mL, 120 mL; Hemangiol®
- Raltegravir: Tablet 600 mg (as potassium); Isentress HD®
- Ribociclib: Tablet 200 mg; Kisqali®
- Rituximab: Solution for subcutaneous injection containing rituximab 1400 mg in 11.7 mL, Solution for I.V. infusion 100 mg in 10 mL, Solution for I.V.infusion 500 mg in 50 mL; Mabthera® SC, Mabthera®
- Saxagliptin with dapagliflozin: Tablet containing saxagliptin 5 mg with dapaglifozin 10 mg; Qtern®
- Sofosbuvir with velpatasvir: Tablet containing 400 mg sofosbuvir with 100 mg velpatasvir; Epclusa®
- Secukinumab: Injection 150 mg in 1 mL pre-filled pen; Cosentyx®
- Somatropin: All forms and strengths; All brands
- Tenofovir with emtricitabine: Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg; Truvada®
- Tenofovir with emtricitabine: Tablet containing tenofovir disoproxil maleate 300 mg with emtricitabine 200 mg ;Tenofovir Disoproxil Emtricitabine Mylan 300/200®
- Tiotropium: Solution for oral inhalation 2.5 micrograms (as bromide monohydrate) per actuation (60 actuations); Spiriva®, Respimat®
- Trifluridine with tipiracil: Tablet containing 15 mg trifluridine with 6.14 mg tipiracil (as hydrochloride) Tablet containing 20 mg trifluridine with 8.19 mg tipiracil (as hydrochloride); Lonsurf®
- Triglycerides medium chain formula: Oral powder 400 g (Monogen) Monogen®
- Venetoclax: Tablet 10 mg, Tablet 50 mg, Tablet 100 mg; Venclexta®
- Vinflunine: Solution concentrate (as ditartrate) for I.V. infusion 50 mg in 2 mL, Solution concentrate (as ditartrate) for I.V. infusion 250 mg in 10mL; Javlor®
- Vitamins, minerals and trace elements formula: Sachets containing oral powder 7 g, 30; Phlexy Vits®